Classification
- Anatomical main groupBBlood and blood-forming organs
- Therapeutic subgroupB01
- Pharmacological subgroupB01A
- Chemical subgroupB01AC
- Chemical substanceB01AC25Cangrelor
Where it is registered
Each register and historical list with its number of registrations and a few of them.
United States
FDA · 2 registrations
Canada
Health Canada · 1 registration
Spain
AEMPS · 1 registration
European Union
EMA · 1 registration
At a glance
- ATC code
- B01AC25
- ATC group
- Blood and blood-forming organs
- Registers
- 6
- Historical lists
- 1
- Registrations
- 8
- With their own page
- 7
- Companies
- 3
All medicines with Cangrelor
Human medicines from every register that match Cangrelor by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
8 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Cangrelor | United States | 50MG/VIAL | powder | Marketed | Gland |
| Kengreal | United States | 50MG/VIAL | powder | Marketed | Chiesi |
| Kengrexal | European Union | Authorised | Chiesi Farmaceutici S.p.A. | ||
| Kengrexal 50 MG Polvo Para Concentrado Para Solucion Inyectable y Para Perfusion | Spain | 50 mg | polvo para solución inyectable y para perfusión | Marketed | Chiesi Farmaceutici S.P.A. |
| Kengrexal | Canada | 50 MG / VIAL | Powder For Solution | Marketed | Chiesi Farmaceutici S.P.A. |
| Kengrexal 50 mg poeder voor concentraat voor oplossing voor injectie / infusie | Netherlands | Poeder voor concentraat voor oplossing voor infusie | Authorised | Chiesi Farmaceutici S.p.A. | |
| Kengrexal | Croatia | Marketed | |||
| KENGREXAL 50 mg | Romania | 50mg | pulb. pt. conc. pt. sol. inj./perf. | Status unknown | Chiesi Farmaceutici S.P.A. |